<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35454086</PMID><DateCompleted><Year>2022</Year><Month>04</Month><Day>26</Day></DateCompleted><DateRevised><Year>2022</Year><Month>07</Month><Day>16</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2218-273X</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>4</Issue><PubDate><Year>2022</Year><Month>Mar</Month><Day>24</Day></PubDate></JournalIssue><Title>Biomolecules</Title><ISOAbbreviation>Biomolecules</ISOAbbreviation></Journal><ArticleTitle>Alteration of the Neuromuscular Junction and Modifications of Muscle Metabolism in Response to Neuron-Restricted Expression of the CHMP2B<sup>intron5</sup> Mutant in a Mouse Model of ALS-FTD Syndrome.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">497</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/biom12040497</ELocationID><Abstract><AbstractText>CHMP2B is a protein that coordinates membrane scission events as a core component of the ESCRT machinery. Mutations in CHMP2B are an uncommon cause of amyotrophic lateral sclerosis (ALS) and frontotemporal dementia (FTD), two neurodegenerative diseases with clinical, genetic, and pathological overlap. Different mutations have now been identified across the ALS-FTD spectrum. Disruption of the neuromuscular junction is an early pathogenic event in ALS. Currently, the links between neuromuscular junction functionality and ALS-associated genes, such as CHMP2B, remain poorly understood. We have previously shown that CHMP2B transgenic mice expressing the CHMP2B<sup>intron5</sup> mutant specifically in neurons develop a progressive motor phenotype reminiscent of ALS. In this study, we used complementary approaches (behavior, histology, electroneuromyography, and biochemistry) to determine the extent to which neuron-specific expression of CHMP2B<sup>intron5</sup> could impact the skeletal muscle characteristics. We show that neuronal expression of the CHMP2B<sup>intron5</sup> mutant is sufficient to trigger progressive gait impairment associated with structural and functional changes in the neuromuscular junction. Indeed, CHMP2B<sup>intron5</sup> alters the pre-synaptic terminal organization and the synaptic transmission that ultimately lead to a switch of fast-twitch glycolytic muscle fibers to more oxidative slow-twitch muscle fibers. Taken together these data indicate that neuronal expression of CHMP2B<sup>intron5</sup> is sufficient to induce a synaptopathy with molecular and functional changes in the motor unit reminiscent of those found in ALS patients.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Waegaert</LastName><ForeName>Robin</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>INSERM U1118 M&#xe9;canismes Centraux et P&#xe9;riph&#xe9;riques de la Neurod&#xe9;g&#xe9;n&#xe9;rescence, Centre de Recherche en Biom&#xe9;decine de Strasbourg, Universit&#xe9; de Strasbourg, 67000 Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Dirrig-Grosch</LastName><ForeName>Sylvie</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>INSERM U1118 M&#xe9;canismes Centraux et P&#xe9;riph&#xe9;riques de la Neurod&#xe9;g&#xe9;n&#xe9;rescence, Centre de Recherche en Biom&#xe9;decine de Strasbourg, Universit&#xe9; de Strasbourg, 67000 Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Haoyi</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>INSERM U1118 M&#xe9;canismes Centraux et P&#xe9;riph&#xe9;riques de la Neurod&#xe9;g&#xe9;n&#xe9;rescence, Centre de Recherche en Biom&#xe9;decine de Strasbourg, Universit&#xe9; de Strasbourg, 67000 Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Boutry</LastName><ForeName>Marion</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>INSERM U1118 M&#xe9;canismes Centraux et P&#xe9;riph&#xe9;riques de la Neurod&#xe9;g&#xe9;n&#xe9;rescence, Centre de Recherche en Biom&#xe9;decine de Strasbourg, Universit&#xe9; de Strasbourg, 67000 Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Luan</LastName><ForeName>Ping</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Medical Center, Shenzhen University Health Science Center, Shenzhen 518060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Loeffler</LastName><ForeName>Jean-Philippe</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>INSERM U1118 M&#xe9;canismes Centraux et P&#xe9;riph&#xe9;riques de la Neurod&#xe9;g&#xe9;n&#xe9;rescence, Centre de Recherche en Biom&#xe9;decine de Strasbourg, Universit&#xe9; de Strasbourg, 67000 Strasbourg, France.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ren&#xe9;</LastName><ForeName>Fr&#xe9;d&#xe9;rique</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>INSERM U1118 M&#xe9;canismes Centraux et P&#xe9;riph&#xe9;riques de la Neurod&#xe9;g&#xe9;n&#xe9;rescence, Centre de Recherche en Biom&#xe9;decine de Strasbourg, Universit&#xe9; de Strasbourg, 67000 Strasbourg, France.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>03</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Biomolecules</MedlineTA><NlmUniqueID>101596414</NlmUniqueID><ISSNLinking>2218-273X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C525139">CHMP2B protein, mouse</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D056827">Endosomal Sorting Complexes Required for Transport</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D009419">Nerve Tissue Proteins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D056827" MajorTopicYN="Y">Endosomal Sorting Complexes Required for Transport</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="Y">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009132" MajorTopicYN="N">Muscles</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009419" MajorTopicYN="Y">Nerve Tissue Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="Y">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">CHMP2Bintron5</Keyword><Keyword MajorTopicYN="N">motor neuron disease</Keyword><Keyword MajorTopicYN="N">motor phenotype</Keyword><Keyword MajorTopicYN="N">neuromuscular junction</Keyword><Keyword MajorTopicYN="N">neurophysiological evaluation</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>12</Month><Day>14</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>3</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>3</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>4</Month><Day>23</Day><Hour>1</Hour><Minute>2</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>4</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>4</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35454086</ArticleId><ArticleId IdType="pmc">PMC9025139</ArticleId><ArticleId IdType="doi">10.3390/biom12040497</ArticleId><ArticleId IdType="pii">biom12040497</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>L&#xf8;mo T. Nerve-muscle interactions. In: St&#xe5;lberg E., editor. Clinical Neurophysiology of Disorders of Muscle and the Neuromuscular Junction in Adults and Children. IFSCN Handbook of Clinical Neurophysiology. Elsevier; Amsterdam, The Netherlands: 2003. pp. 47&#x2013;65.</Citation></Reference><Reference><Citation>Hardiman O., Al-Chalabi A., Chio A., Corr E.M., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., van den Berg L.H. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;5:17071.</Citation><ArticleIdList><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Dengler A., Konstanzer A., K&#xfc;ther G., Hesse S., Wolf W., Struppler A. Amyotrophic lateral sclerosis: Macro-EMG and twitch forces of single motor units. Muscle Nerve. 1990;13:545&#x2013;550. doi: 10.1002/mus.880130612.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.880130612</ArticleId><ArticleId IdType="pubmed">2366827</ArticleId></ArticleIdList></Reference><Reference><Citation>Maselli R.A., Wollman R.L., Leung C., Distad B., Palombi S., Richman D.P., Salazar-Grueso E.F., Roos R.P. Neuromuscular transmission in amyotrophic lateral sclerosis. Muscle Nerve. 1993;16:1193&#x2013;1203.</Citation><ArticleIdList><ArticleId IdType="pubmed">8105377</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer L.R., Culver D.G., Tennant P., Davis A.A., Wang M., Castellano-Sanchez A., Khan J., Polak M.A., Glass J.D. Amyotrophic lateral sclerosis is a distal axonopathy: Evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240.</Citation><ArticleIdList><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Bruneteau G., Bauch&#xe9; S., de Aguilar J.L.G., Brochier G., Mandjee N., Tanguy M.L., Hussain G., Behin A., Khiami F., Sariali E., et al. Endplate denervation correlates with Nogo-A muscle expression in amyotrophic lateral sclerosis patients. Ann. Clin. Transl. Neurol. 2015;2:362&#x2013;372.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4402082</ArticleId><ArticleId IdType="pubmed">25909082</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D., Schneider C., Xu L., Borg J., Spooren W., Caroni P. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 2000;20:2534&#x2013;2542.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Cappello V., Vezzoli E., Righi M., Fossati M., Mariotti R., Crespi A., Patruno M., Bentivoglio M., Pietrini G., Francolini M. Analysis of neuromuscular junctions and effects of anabolic steroid administration in the SOD1G93A mouse model of ALS. Mol. Cell. Neurosci. 2012;51:12&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">22800606</ArticleId></ArticleIdList></Reference><Reference><Citation>Telerman-Toppet N., Co&#xeb;rs C. Motor innervation and fiber type pattern in amyotrophic lateral sclerosis and in Charcot-Marie-Tooth disease. Muscle Nerve. 1978;1:133&#x2013;139.</Citation><ArticleIdList><ArticleId IdType="pubmed">155778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharp P.S., Dick J.R., Greensmith L. The effect of peripheral nerve injury on disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Neuroscience. 2005;130:897&#x2013;910.</Citation><ArticleIdList><ArticleId IdType="pubmed">15652988</ArticleId></ArticleIdList></Reference><Reference><Citation>Palamiuc L., Schlagowski A., Ngo S.T., Vernay A., Dirrig-Grosch S., Henriques A., Boutillier A.L., Zoll J., Echaniz-Laguna A., Loeffler J.P., et al. A metabolic switch toward lipid use in glycolytic muscle is an early pathologic event in a mouse model of amyotrophic lateral sclerosis. EMBO Mol. Med. 2015;7:526&#x2013;546.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4492815</ArticleId><ArticleId IdType="pubmed">25820275</ArticleId></ArticleIdList></Reference><Reference><Citation>Echaniz-Laguna A., Zoll J., Ponsot E., N'guessan B., Tranchant C., Loeffler J.P., Lampert E. Muscular mitochondrial function in amyotrophic lateral sclerosis is progressively altered as the disease develops: A temporal study in man. Exp. Neurol. 2006;198:25&#x2013;30.</Citation><ArticleIdList><ArticleId IdType="pubmed">16126198</ArticleId></ArticleIdList></Reference><Reference><Citation>Steyn F.J., Li R., Kirk S.E., Tefera T.W., Xie T.Y., Tracey T.J., Kelk D., Wimberger E., Garton F.C., Roberts L., et al. Altered skeletal muscle glucose-fatty acid flux in amyotrophic lateral sclerosis. Brain Commun. 2020;2:fcaa154.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7677608</ArticleId><ArticleId IdType="pubmed">33241210</ArticleId></ArticleIdList></Reference><Reference><Citation>Scaricamazza S., Salvatori I., Amadio S., Nesci V., Torcinaro A., Giacovazzo G., Primiano A., Gloriani M., Candelise N., Pieroni L., et al. Repurposing of Trimetazidine for Amyotrophic Lateral Sclerosis: A study in SOD1G93A mice. Br. J. Pharmacol. 2021;179:1732&#x2013;1752. doi: 10.1111/bph.15738.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/bph.15738</ArticleId><ArticleId IdType="pubmed">34783031</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaarsma D., Teuling E., Haasdijk E.D., De Zeeuw C.I., Hoogenraad C.C. Neuron-specific expression of mutant superoxide dismutase is sufficient to induce amyotrophic lateral sclerosis in transgenic mice. J. Neurosci. 2008;28:2075&#x2013;2088.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6671838</ArticleId><ArticleId IdType="pubmed">18305242</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L., Sharma K., Deng H.X., Siddique T., Grisotti G., Liu E., Roos R.P. Restricted expression of mutant SOD1 in spinal motor neurons and interneurons induces motor neuron pathology. Neurobiol. Dis. 2008;29:400&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">18054242</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M., Martin L.J. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 2010;19:2284&#x2013;2302.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G., Lepore E., Martini M., Barberi L., Nunn A., Scicchitano B.M., Musar&#xf2; A. Metabolic Changes Associated With Muscle Expression of SOD1G93A. Front. Physiol. 2018;9:831.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6048270</ArticleId><ArticleId IdType="pubmed">30042688</ArticleId></ArticleIdList></Reference><Reference><Citation>Martin L.J., Wong M. Skeletal Muscle-Restricted Expression of Human SOD1 in Transgenic Mice Causes a Fatal ALS-Like Syndrome. Front. Neurol. 2020;11:592851.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7767933</ArticleId><ArticleId IdType="pubmed">33381076</ArticleId></ArticleIdList></Reference><Reference><Citation>Chia R., Chi&#xf2; A., Traynor B.J. Novel genes associated with amyotrophic lateral sclerosis: Diagnostic and clinical implications. Lancet Neurol. 2018;17:94&#x2013;102.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5901717</ArticleId><ArticleId IdType="pubmed">29154141</ArticleId></ArticleIdList></Reference><Reference><Citation>Skibinski G., Parkinson N.J., Brown J.M., Chakrabarti L., Lloyd S.L., Hummerich H., Nielsen J.E., Hodges J.R., Spillantini M.G., Thusgaard T., et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat. Genet. 2005;37:806&#x2013;808.</Citation><ArticleIdList><ArticleId IdType="pubmed">16041373</ArticleId></ArticleIdList></Reference><Reference><Citation>Parkinson N., Ince P.G., Smith M.O., Highley R., Skibinski G., Andersen P.M., Morrison K.E., Pall H.S., Hardiman O., Collinge J., et al. MRC Proteomics in ALS Study; FReJA Consortium. ALS phenotypes with mutations in CHMP2B (charged multivesicular body protein 2B) Neurology. 2006;67:1074&#x2013;1077.</Citation><ArticleIdList><ArticleId IdType="pubmed">16807408</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Zee J., Urwin H., Engelborghs S., Bruyland M., Vandenberghe R., Dermaut B., De Pooter T., Peeters K., Santens P., De Deyn P.P., et al. CHMP2B C-truncating mutations in frontotemporal lobar degeneration are associated with an aberrant endosomal phenotype in vitro. Hum. Mol. Genet. 2008;17:313&#x2013;322.</Citation><ArticleIdList><ArticleId IdType="pubmed">17956895</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox L.E., Ferraiuolo L., Goodall E.F., Heath P.R., Higginbottom A., Mortiboys H., Hollinger H.C., Hartley J.A., Brockington A., Burness C.E., et al. Mutations in CHMP2B in lower motor neuron predominant amyotrophic lateral sclerosis (ALS) PLoS ONE. 2010;5:e9872.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2844426</ArticleId><ArticleId IdType="pubmed">20352044</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghanim M., Guillot-Noel L., Pasquier F., Jornea L., Deramecourt V., Dubois B., Le Ber I., Brice A., French Research Network on FTD and FTD/MND CHMP2B mutations are rare in French families with frontotemporal lobar degeneration. J. Neurol. 2010;257:2032&#x2013;2036.</Citation><ArticleIdList><ArticleId IdType="pubmed">20625756</ArticleId></ArticleIdList></Reference><Reference><Citation>van Blitterswijk M., Vlam L., van Es M.A., van der Pol W.L., Hennekam E.A., Dooijes D., Schelhaas H.J., van der Kooi A.J., de Visser M., Veldink J.H., et al. Genetic overlap between apparently sporadic motor neuron diseases. PLoS ONE. 2012;7:e48983.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3498376</ArticleId><ArticleId IdType="pubmed">23155438</ArticleId></ArticleIdList></Reference><Reference><Citation>Narain P., Pandey A., Gupta S., Gomes J., Bhatia R., Vivekanandan P. Targeted next-generation sequencing reveals novel and rare variants in Indian patients with amyotrophic lateral sclerosis. Neurobiol. Aging. 2018;71:265.e9&#x2013;265.e14.</Citation><ArticleIdList><ArticleId IdType="pubmed">29895397</ArticleId></ArticleIdList></Reference><Reference><Citation>Puppala G.K., Gorthi S.P., Chandran V., Gundabolu G. Frontotemporal Dementia&#x2014;Current Concepts. Neurol. India. 2021;69:1144&#x2013;1152.</Citation><ArticleIdList><ArticleId IdType="pubmed">34747778</ArticleId></ArticleIdList></Reference><Reference><Citation>Sadoul R., Laporte M.H., Chassefeyre R., Chi K.I., Goldberg Y., Chatellard C., Hemming F.J., Fraboulet S. The role of ESCRT during development and functioning of the nervous system. Semin. Cell Dev. Biol. 2018;74:40&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pubmed">28811263</ArticleId></ArticleIdList></Reference><Reference><Citation>Henne W.M., Buchkovich N.J., Emr S.D. The ESCRT pathway. Dev. Cell. 2011;21:77&#x2013;91.</Citation><ArticleIdList><ArticleId IdType="pubmed">21763610</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghazi-Noori S., Froud K.E., Mizielinska S., Powell C., Smidak M., de Marco M.F., O'Malley C., Farmer M., Parkinson N., Fisher E.M., et al. Progressive neuronal inclusion formation and axonal degeneration in CHMP2B mutant transgenic mice. Pt 3Brain. 2012;135:819&#x2013;832.</Citation><ArticleIdList><ArticleId IdType="pubmed">22366797</ArticleId></ArticleIdList></Reference><Reference><Citation>Vernay A., Therreau L., Blot B., Risson V., Dirrig-Grosch S., Waegaert R., Lequeu T., Sellal F., Schaeffer L., Sadoul R., et al. A transgenic mouse expressing CHMP2Bintron5 mutant in neurons develops histological and behavioural features of amyotrophic lateral sclerosis and frontotemporal dementia. Hum. Mol. Genet. 2016;25:3341&#x2013;3360.</Citation><ArticleIdList><ArticleId IdType="pubmed">27329763</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton E.L., Mancuso R., Nielsen T.T., Mizielinska S., Holmes H., Powell N., Norona F., Larsen J.O., Milioto C., Wilson K.M., et al. Early microgliosis precedes neuronal loss and behavioural impairment in mice with a frontotemporal dementia-causing CHMP2B mutation. Hum. Mol. Genet. 2017;26:873&#x2013;887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5409096</ArticleId><ArticleId IdType="pubmed">28093491</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng G., Mellor R.H., Bernstein M., Keller-Peck C., Nguyen Q.T., Wallace M., Nerbonne J.M., Lichtman J.W., Sanes J.R. Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP. Neurotechnique. 2000;28:41&#x2013;51.</Citation><ArticleIdList><ArticleId IdType="pubmed">11086982</ArticleId></ArticleIdList></Reference><Reference><Citation>Hamers F.P.T., Koopmans G.C., Joosten E.A.J. CatWalk assisted gait analysis in the assessment of spinal cord injury. J. Neurotrauma. 2006;24:537&#x2013;548.</Citation><ArticleIdList><ArticleId IdType="pubmed">16629635</ArticleId></ArticleIdList></Reference><Reference><Citation>G&#xf3;rska T., Zmys&#x142;owski W., Majczy&#x144;ski H. Overground locomotion in intact rats: Interlimb coordination, support patterns and support phases duration. Acta Neurobiol. Exp. (Wars) 1999;59:131&#x2013;144.</Citation><ArticleIdList><ArticleId IdType="pubmed">10497818</ArticleId></ArticleIdList></Reference><Reference><Citation>Dupuis L., Gonzalez de Aguilar J.L., Echaniz-Laguna A., Eschbach J., Rene F., Oudart H., Halter B., Huze C., Schaeffer L., Bouillaud F., et al. Muscle mitochondrial uncoupling dismantles neuromuscular junction and triggers distal degeneration of motor neurons. PLoS ONE. 2009;4:e5390.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2671839</ArticleId><ArticleId IdType="pubmed">19404401</ArticleId></ArticleIdList></Reference><Reference><Citation>Echaniz-Laguna A., Rene F., Marcel C., Bangratz M., Fontaine B., Loeffler J.P., Nicole S. Electrophysiological studies in a mouse model of Schwartz- Jampel syndrome demonstrate muscle fiber hyperactivity of peripheral nerve origin. Muscle Nerve. 2009;40:55&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">19367640</ArticleId></ArticleIdList></Reference><Reference><Citation>Oosthuyse B., Moons L., Storkebaum E., Beck H., Nuyens D., Brusselmans K., Van Dorpe J., Hellings P., Gorselink M., Heymans S., et al. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat. Genet. 2001;28:131&#x2013;138.</Citation><ArticleIdList><ArticleId IdType="pubmed">11381259</ArticleId></ArticleIdList></Reference><Reference><Citation>Pestronk G.J., Kaiser K.K., Brooke M.H. ATPase stain in muscle histochemistry. Muscle Nerve. 1992;15:258.</Citation><ArticleIdList><ArticleId IdType="pubmed">1372392</ArticleId></ArticleIdList></Reference><Reference><Citation>H&#xe4;m&#xe4;l&#xe4;inen N., Pette D. The histochemical profiles of fast fiber types IIB, IID, and IIA in skeletal muscles of mouse, rat, and rabbit. J. Histochem. Cytochem. 1993;41:733&#x2013;743.</Citation><ArticleIdList><ArticleId IdType="pubmed">8468455</ArticleId></ArticleIdList></Reference><Reference><Citation>Pinheiro-Dardis C.M., Erbereli B.T., Gigo-Benato D., Castro P.A.T.S., Russo T.L. Electrical stimulation delays reinnervation in denervated rat muscle. Muscle Nerve. 2017;56:E108&#x2013;E118.</Citation><ArticleIdList><ArticleId IdType="pubmed">28120411</ArticleId></ArticleIdList></Reference><Reference><Citation>Duclert A., Changeux J.P. Acetylcholine receptor gene expression at the developing neuromuscular junction. Physiol. Rev. 1995;75:339&#x2013;368.</Citation><ArticleIdList><ArticleId IdType="pubmed">7724666</ArticleId></ArticleIdList></Reference><Reference><Citation>Schiaffino S., Reggiani C. Fiber types in mammalian skeletal muscles. Physiol. Rev. 2011;91:1447&#x2013;1531.</Citation><ArticleIdList><ArticleId IdType="pubmed">22013216</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.A., Beigneux A., Ahmad S.T., Young S.G., Gao F.B. ESCRT-III dysfunction causes autophagosome accumulation and neurodegeneration. Curr. Biol. 2007;17:1561&#x2013;1567.</Citation><ArticleIdList><ArticleId IdType="pubmed">17683935</ArticleId></ArticleIdList></Reference><Reference><Citation>Belly A., Bodon G., Blot B., Bouron A., Sadoul R., Goldberg Y. CHMP2B mutants linked to frontotemporal dementia impair maturation of dendritic spines. Pt 17J. Cell Sci. 2010;123:2943&#x2013;2954.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3013364</ArticleId><ArticleId IdType="pubmed">20699355</ArticleId></ArticleIdList></Reference><Reference><Citation>Gascon E., Lynch K., Ruan H., Almeida S., Verheyden J.M., Seeley W.W., Dickson D.W., Petrucelli L., Sun D., Jiao J., et al. Alterations in microRNA-124 and AMPA receptors contribute to social behavioral deficits in frontotemporal dementia. Nat. Med. 2014;20:1444&#x2013;1451.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4257887</ArticleId><ArticleId IdType="pubmed">25401692</ArticleId></ArticleIdList></Reference><Reference><Citation>Chassefeyre R., Mart&#xed;nez-Hern&#xe1;ndez J., Bertaso F., Bouquier N., Blot B., Laporte M., Fraboulet S., Cout&#xe9; Y., Devoy A., Isaacs A.M., et al. Regulation of postsynaptic function by the dementia-related ESCRT-III subunit CHMP2B. J. Neurosci. 2015;35:3155&#x2013;3173.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4331633</ArticleId><ArticleId IdType="pubmed">25698751</ArticleId></ArticleIdList></Reference><Reference><Citation>Ugbode C., West R.J.H. Lessons learned from CHMP2B, implications for frontotemporal dementia and amyotrophic lateral sclerosis. Neurobiol. Dis. 2021;147:105144.</Citation><ArticleIdList><ArticleId IdType="pubmed">33144171</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S., Santos A.F., Saxena S., Xu L., Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 2006;9:408&#x2013;419.</Citation><ArticleIdList><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Caroni P. Overexpression of growth-associated proteins in the neurons of adult transgenic mice. J. Neurosci. Methods. 1997;71:3&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">9125370</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xe9;ger B., Vergani L., Sorar&#xf9; G., Hespel P., Derave W., Gobelet C., D'Ascenzio C., Angelini C., Russell A.P. Human skeletal muscle atrophy in amyotrophic lateral sclerosis reveals a reduction in Akt and an increase in atrogin-1. FASEB J. 2006;20:583&#x2013;585.</Citation><ArticleIdList><ArticleId IdType="pubmed">16507768</ArticleId></ArticleIdList></Reference><Reference><Citation>Kimura N., Kumamoto T., Oniki T., Nomura M., Nakamura K., Abe Y., Hazama Y., Ueyama H. Role of ubiquitin-proteasome proteolysis in muscle fiber destruction in experimental chloroquine-induced myopathy. Muscle Nerve. 2009;39:521&#x2013;528.</Citation><ArticleIdList><ArticleId IdType="pubmed">19296457</ArticleId></ArticleIdList></Reference><Reference><Citation>Lima S.C., Caier&#xe3;o Q.M., Peviani S.M., Russo T.L., Somazz M.C., Salvini T.F., Teodori R.M., Minamoto V.B. Muscle and nerve responses after different intervals of electrical stimulation sessions on denervated rat muscle. Am. J. Phys. Med. Rehabil. 2009;88:126&#x2013;135.</Citation><ArticleIdList><ArticleId IdType="pubmed">18787495</ArticleId></ArticleIdList></Reference><Reference><Citation>Meinen S., Lin S., R&#xfc;egg M.A., Punga A.R. Fatigue and muscle atrophy in a mouse model of myasthenia gravis is paralleled by loss of sarcolemmal nNOS. PLoS ONE. 2012;7:e44148.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3429452</ArticleId><ArticleId IdType="pubmed">22952904</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams L., Carlson B.M., Henderson L., Goldman D. Adaptation of nicotinic acetylcholine receptor, myogenin, and MRF4 gene expression to long-term muscle denervation. J. Cell Biol. 1995;131:1341&#x2013;1349.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2120634</ArticleId><ArticleId IdType="pubmed">8522594</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J., Shen J., Lee C.A., Elsaidi G.A., Smith T.L., Walker F.O., Rushing J.T., Tan K.H., Koman L.A., Smith B.P. Gene expression of nAChR, SNAP-25 and GAP-43 in skeletal muscles following botulinum toxin A injection: A study in rats. J. Orthop. Res. 2005;23:302&#x2013;309.</Citation><ArticleIdList><ArticleId IdType="pubmed">15734240</ArticleId></ArticleIdList></Reference><Reference><Citation>Halter B., de Aguilar J.L.G., Rene F., Petri S., Fricker B., Echaniz-Laguna A., Dupuis L., Larmet Y., Loeffler J.P. Oxidative stress in skeletal muscle stimulates early expression of Rad in a mouse model of amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2010;48:915&#x2013;923.</Citation><ArticleIdList><ArticleId IdType="pubmed">20079427</ArticleId></ArticleIdList></Reference><Reference><Citation>Mori A., Yamashita S., Nakajima M., Hori H., Tawara A., Matsuo Y., Misumi Y., Ando Y. CMAP decrement as a potential diagnostic marker for ALS. Acta Neurol. Scand. 2016;134:49&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">26434688</ArticleId></ArticleIdList></Reference><Reference><Citation>Alanazy M.H., Hegedus J., White C., Korngut L. Decremental responses in patients with motor neuron disease. Brain Behav. 2017;7:e00846.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5698864</ArticleId><ArticleId IdType="pubmed">29201547</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun X.S., Liu W.X., Chen Z.H., Ling L., Yang F., Wang H.F., Cui F., Huang X.S. Repetitive Nerve Stimulation in Amyotrophic Lateral Sclerosis. Chin. Med. J. 2018;131:2146&#x2013;2151.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6144859</ArticleId><ArticleId IdType="pubmed">30203787</ArticleId></ArticleIdList></Reference><Reference><Citation>Souayah N., Coakley K.M., Chen R., Ende N., McArdle J.J. Defective neuromuscular transmission in the SOD1 G93A transgenic mouse improves after administration of human umbilical cord blood cells. Stem Cell Rev. Rep. 2012;8:224&#x2013;228.</Citation><ArticleIdList><ArticleId IdType="pubmed">21678037</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma A., Lyashchenko A.K., Lu L., Nasrabady S.E., Elmaleh M., Mendelsohn M., Nemes A., Tapia J.C., Mentis G.Z., Shneider N.A. ALS-associated mutant FUS induces selective motor neuron degeneration through toxic gain of function. Nat. Commun. 2016;7:10465.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4742863</ArticleId><ArticleId IdType="pubmed">26842965</ArticleId></ArticleIdList></Reference><Reference><Citation>Vinsant S., Mansfield C., Jimenez-Moreno R., Del Gaizo Moore V., Yoshikawa M., Hampton T.G., Prevette D., Caress J., Oppenheim R.W., Milligan C. Characterization of early pathogenesis in the SOD1(G93A) mouse model of ALS: Part I, background and methods. Brain Behav. 2013;3:335&#x2013;350.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3869677</ArticleId><ArticleId IdType="pubmed">24381807</ArticleId></ArticleIdList></Reference><Reference><Citation>So E., Mitchell J.C., Memmi C., Chennell G., Vizcay-Barrena G., Allison L., Shaw C.E., Vance C. Mitochondrial abnormalities and disruption of the neuromuscular junction precede the clinical phenotype and motor neuron loss in hFUSWT transgenic mice. Hum. Mol. Genet. 2018;27:463&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886082</ArticleId><ArticleId IdType="pubmed">29194538</ArticleId></ArticleIdList></Reference><Reference><Citation>Clayton E.L., Bonnycastle K., Isaacs A.M., Cousin M.A., Schorge S. A novel synaptopathy-defective synaptic vesicle protein trafficking in the mutant CHMP2B mouse model of frontotemporal dementia. J. Neurochem. 2021;160:412&#x2013;425. doi: 10.1111/jnc.15551.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.15551</ArticleId><ArticleId IdType="pubmed">34855215</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L.J., Zhang C., Chen C. Research progress on vesicle cycle and neurological disorders. J. Pharm. Pharm. Sci. 2021;24:400&#x2013;441.</Citation><ArticleIdList><ArticleId IdType="pubmed">34343470</ArticleId></ArticleIdList></Reference><Reference><Citation>Tremblay E., Martineau &#xc9;., Robitaille R. Opposite Synaptic Alterations at the Neuromuscular Junction in an ALS Mouse Model: When Motor Units Matter. J. Neurosci. 2017;37:8901&#x2013;8918.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6596800</ArticleId><ArticleId IdType="pubmed">28821658</ArticleId></ArticleIdList></Reference><Reference><Citation>Chand K.K., Lee K.M., Lee J.D., Qiu H., Willis E.F., Lavidis N.A., Hilliard M.A., Noakes P.G. Defects in synaptic transmission at the neuromuscular junction precede motor deficits in a TDP-43Q331K transgenic mouse model of amyotrophic lateral sclerosis. FASEB J. 2018;32:2676&#x2013;2689.</Citation><ArticleIdList><ArticleId IdType="pubmed">29295857</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J.A., Liu L., Gao F.B. Autophagy defects contribute to neurodegeneration induced by dysfunctional ESCRT-III. Autophagy. 2009;5:1070&#x2013;1072.</Citation><ArticleIdList><ArticleId IdType="pubmed">19738424</ArticleId></ArticleIdList></Reference><Reference><Citation>Nielsen T.T., Mizielinska S., Hasholt L., Isaacs A.M., Nielsen J.E., FReJA Consortium Reversal of pathology in CHMP2B-mediated frontotemporal dementia patient cells using RNA interference. J. Gene Med. 2012;14:521&#x2013;529.</Citation><ArticleIdList><ArticleId IdType="pubmed">22786763</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Schmid B., Nikolaisen N.K., Rasmussen M.A., Aldana B.I., Agger M., Calloe K., Stummann T.C., Larsen H.M., Nielsen T.T., et al. Patient iPSC-Derived Neurons for Disease Modeling of Frontotemporal Dementia with Mutation in CHMP2B. Stem Cell Rep. 2017;8:648&#x2013;658.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5355623</ArticleId><ArticleId IdType="pubmed">28216144</ArticleId></ArticleIdList></Reference><Reference><Citation>West R.J.H., Ugbode C., Fort-Aznar L., Sweeney S.T. Neuroprotective activity of ursodeoxycholic acid in CHMP2B(Intron5) models of frontotemporal dementia. Neurobiol. Dis. 2020;144:105047.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7491204</ArticleId><ArticleId IdType="pubmed">32801000</ArticleId></ArticleIdList></Reference><Reference><Citation>Urwin H., Authier A., Nielsen J.E., Metcalf D., Powell C., Froud K., Malcolm D.S., Holm I., Johannsen P., Brown J., et al. Disruption of endocytic trafficking in frontotemporal dementia with CHMP2B mutations. Hum. Mol. Genet. 2010;19:2228&#x2013;2238.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2865375</ArticleId><ArticleId IdType="pubmed">20223751</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin A., Perera N.D., Beart P.M., Turner B.J., Shabanpoor F. Amyotrophic Lateral Sclerosis and Autophagy: Dysfunction and Therapeutic Targeting. Cells. 2020;9:2413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7694295</ArticleId><ArticleId IdType="pubmed">33158177</ArticleId></ArticleIdList></Reference><Reference><Citation>Pette D., Vrbov&#xe1; G. What does chronic electrical stimulation teach us about muscle plasticity? Muscle Nerve. 1999;6:666&#x2013;677.</Citation><ArticleIdList><ArticleId IdType="pubmed">10366220</ArticleId></ArticleIdList></Reference><Reference><Citation>Hegedus J., Putman C.T., Gordon T. Time course of preferential motor unit loss in the SOD1G93A mouse model of amyotrophic lateral sclerosis. Neurobiol. Dis. 2007;28:154&#x2013;164.</Citation><ArticleIdList><ArticleId IdType="pubmed">17766128</ArticleId></ArticleIdList></Reference><Reference><Citation>Deforges S., Branchu J., Biondi O., Grondard C., Pariset C., L&#xe9;colle S., Lopes P., Vidal P.P., Chanoine C., Charbonnier F. Motoneuron survival is promoted by specific exercise in a mouse model of amyotrophic lateral sclerosis. Pt 14J. Physiol. 2009;587:3561&#x2013;3572.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2742281</ArticleId><ArticleId IdType="pubmed">19491245</ArticleId></ArticleIdList></Reference><Reference><Citation>Feige J.N., Auwerx J. Transcriptional coregulators in the control of energy homeostasis. Trends Cell Biol. 2007;17:292&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">17475497</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordon T., Hegedus J., Tam S.L. Adaptive and maladaptive motor axonal sprouting in aging and motoneuron disease. Neurol. Res. 2004;26:174&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">15072637</ArticleId></ArticleIdList></Reference><Reference><Citation>Baloh R.H., Rakowicz W., Gardner R., Pestronk A. Frequent atrophic groups with mixed-type myofibers is distinctive to motor neuron syndromes. Muscle Nerve. 2007;36:107&#x2013;110.</Citation><ArticleIdList><ArticleId IdType="pubmed">17299742</ArticleId></ArticleIdList></Reference><Reference><Citation>Chivet M., Marchioretti C., Pirazzini M., Piol D., Scaramuzzino C., Polanco M.J., Romanello V., Zuccaro E., Parodi S., D'Antonio M., et al. Polyglutamine-Expanded Androgen Receptor Alteration of Skeletal Muscle Homeostasis and Myonuclear Aggregation Are Affected by Sex, Age and Muscle Metabolism. Cells. 2020;9:325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7072234</ArticleId><ArticleId IdType="pubmed">32019272</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>